Literature DB >> 17335408

Mesoporous silicon: a platform for the delivery of therapeutics.

Clive A Prestidge1, Timothy J Barnes, Chi-Hian Lau, Christian Barnett, Armando Loni, Leigh Canham.   

Abstract

Nanostructuring materials can radically change their properties. Two interesting examples highlighted here are nanoscale porosity inducing biodegradability, and nanoscale confinement affecting the physical form of an entrapped drug. Mesoporous silicon is under increasing study for drug-delivery applications, and is the topic of this review. The authors focus on those properties of most relevance to this application, as well as those recent studies published on small molecule and peptide/protein delivery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17335408     DOI: 10.1517/17425247.4.2.101

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  22 in total

1.  Processability of AquaSolve™ LG polymer by hot-melt extrusion: Effects of pressurized CO2 on physicomechanical properties and API stability.

Authors:  Mashan Almutairi; Bjad Almutairy; Sandeep Sarabu; Ahmed Almotairy; Eman Ashour; Suresh Bandari; Amol Batra; Divya Tewari; T Durig; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2019-04-18       Impact factor: 3.981

2.  Sustained small interfering RNA delivery by mesoporous silicon particles.

Authors:  Takemi Tanaka; Lingegowda S Mangala; Pablo E Vivas-Mejia; René Nieves-Alicea; Aman P Mann; Edna Mora; Hee-Dong Han; Mian M K Shahzad; Xuewu Liu; Rohan Bhavane; Jianhua Gu; Jean R Fakhoury; Ciro Chiappini; Chunhua Lu; Koji Matsuo; Biana Godin; Rebecca L Stone; Alpa M Nick; Gabriel Lopez-Berestein; Anil K Sood; Mauro Ferrari
Journal:  Cancer Res       Date:  2010-05-01       Impact factor: 12.701

3.  Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.

Authors:  Angel Tan; Andrew K Davey; Clive A Prestidge
Journal:  Pharm Res       Date:  2011-05-11       Impact factor: 4.200

4.  Degradation and biocompatibility of multistage nanovectors in physiological systems.

Authors:  Jonathan O Martinez; Michael Evangelopoulos; Ciro Chiappini; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  J Biomed Mater Res A       Date:  2013-11-16       Impact factor: 4.396

5.  Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs.

Authors:  Jonathan O Martinez; Michael Evangelopoulos; Rohan Bhavane; Stefania Acciardo; Francesco Salvatore; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

6.  Biodegradable porous silicon barcode nanowires with defined geometry.

Authors:  Ciro Chiappini; Xuewu Liu; Jean Raymond Fakhoury; Mauro Ferrari
Journal:  Adv Funct Mater       Date:  2010-07-23       Impact factor: 18.808

7.  Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system.

Authors:  Enrica De Rosa; Ciro Chiappini; Dongmei Fan; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Pharm Res       Date:  2011-05-24       Impact factor: 4.200

Review 8.  Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer.

Authors:  Hareesh B Nair; Bokyung Sung; Vivek R Yadav; Ramaswamy Kannappan; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2010-07-21       Impact factor: 5.858

9.  Low pressure mediated enhancement of nanoparticle and macromolecule loading into porous silicon structures.

Authors:  Fransisca Leonard; Katrin Margulis-Goshen; Xuewu Liu; Srimeenakshi Srinivasan; Shlomo Magdassi; Biana Godin
Journal:  Mesoporous Biomater       Date:  2014

Review 10.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.